---
title: Cassia, LLC vs uBriGene
slug_a: cassiallc
slug_b: ubrigene
site: cro
review_signal_gate: closed
canonical_path: /compare/cassiallc/ubrigene
generated_by: BioBM Editorial AI
---

# Cassia, LLC vs uBriGene

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Cassia, LLC (cassiallc) is listed for cro. Cassia, LLC is a San Diego-based CRO specializing in green chemo-enzymatic synthesis of stable-isotope labeled metabolites, proteins, and nucleic acids, plus LC-MS/MS RNA modification mapping services for discovery and therapeutic development.

Services: 4. Modalities: 2. Indications: 3. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

uBriGene (ubrigene) is listed for both. uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.